MAPK8 and non-small cell lung carcinoma: Compound K inhibited proliferation, augmented autophagy, and apoptosis of non-small cell lung cancer (NSCLC) (A549 and H1975) cells through the mammalian target of rapamycin (mTOR)/AMPK and JNK signaling pathways (Table 4) [82].